AI-generated summary
The authors compared photobiomodulation with a low-power laser against nimesulide, an anti-inflammatory drug, after diode laser removal of lower lip lesions in 13 cases. Patients given photobiomodulation reported less pain at follow-up, though the difference was not statistically significant, and their surgical wounds were smaller at seven days. The authors suggest photobiomodulation may be an alternative to nimesulide.
- Participants
- 13
- Who or what was studied
- Patients who underwent surgical removal of lower lip lesions with a high-power diode laser; mean age 44.7 years and 53.8% male.
- Wavelengths
- 808, 660 nm
- Limits stated in the abstract
- The study is a case series of only 13 subjects split into two small groups, and the pain difference was not statistically significant.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm, 660 nm
- Power
- 2.5 W, 40 mW
- Total energy
- 1 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation, Photobiomodulation therapy, Visual analogue scale, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.